Racemic-trans-(3-((4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)(3-fluoro-4-hydroxypyrrolidin-1-yl)methanone Hydrochloride

ID: ALA4079398

PubChem CID: 132253084

Max Phase: Preclinical

Molecular Formula: C18H18ClF4N3O3

Molecular Weight: 399.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cl.NCc1cc(Oc2cccc(C(=O)N3C[C@@H](O)[C@H](F)C3)c2)nc(C(F)(F)F)c1

Standard InChI:  InChI=1S/C18H17F4N3O3.ClH/c19-13-8-25(9-14(13)26)17(27)11-2-1-3-12(6-11)28-16-5-10(7-23)4-15(24-16)18(20,21)22;/h1-6,13-14,26H,7-9,23H2;1H/t13-,14-;/m1./s1

Standard InChI Key:  WCLUQDIEECAJLM-DTPOWOMPSA-N

Molfile:  

     RDKit          2D

 29 30  0  0  0  0  0  0  0  0999 V2000
   28.8716   -3.2189    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   25.8450   -1.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8438   -2.5774    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5587   -2.9903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2751   -2.5769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2722   -1.7464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5569   -1.3372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9852   -1.3311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7012   -1.7410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5585   -3.8153    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.8439   -4.2276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1329   -3.8119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4189   -4.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4182   -5.0494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1376   -5.4619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8487   -5.0479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1304   -1.3377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1302   -0.5127    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   24.4160   -1.7503    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   24.4130   -0.9250    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.1403   -6.2869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4272   -6.7018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.8561   -6.6971    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.6733   -6.3711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1233   -6.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5382   -7.6992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3446   -7.5249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3025   -6.9025    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.2052   -8.4540    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  6  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  2 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 15 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 22  1  0
 25 28  1  6
 26 29  1  1
M  END

Associated Targets(Human)

LOXL2 Tchem Lysyl oxidase homolog 2 (834 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX Tchem Lysyl oxidase (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOXL3 Tchem Lysyl oxidase homolog 3 (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AOC3 Tchem Amine oxidase, copper containing (450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AOC1 Tchem Diamine oxidase (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOB Tclin Monoamine oxidase B (8835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lung (1108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Loxl2 Lysyl oxidase homolog 2 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 399.34Molecular Weight (Monoisotopic): 399.1206AlogP: 2.51#Rotatable Bonds: 4
Polar Surface Area: 88.68Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.48CX Basic pKa: 8.84CX LogP: 2.00CX LogD: 0.55
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.77Np Likeness Score: -1.17

References

1. Rowbottom MW, Bain G, Calderon I, Lasof T, Lonergan D, Lai A, Huang F, Darlington J, Prodanovich P, Santini AM, King CD, Goulet L, Shannon KE, Ma GL, Nguyen K, MacKenna DA, Evans JF, Hutchinson JH..  (2017)  Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2).,  60  (10): [PMID:28471663] [10.1021/acs.jmedchem.7b00345]
2.  (2018)  Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making,